Sharp Shalini
SEC CIK 1377202 · EDGAR
BoughtSold
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
| 16 | Sharp Shalini | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 17:49 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Sharp Shalini | Dir | A - Grant | $0.00 | +19.0K | 38.1K | +99% | $0 | |
| D | 2026-05-21 19:24 | 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | Sharp Shalini | Dir | M - OptEx | $0.00 | +1,659 | 4,088 | +68% | $0 |
| D | 2025-05-22 | 2025-05-21 | ONC | BeOne Medicines Ltd. | Sharp Shalini | Dir | A - Grant | $0.00 | +11.0K | 19.1K | +135% | $0 |
| D | 2025-05-22 | 2025-05-22 | NBIX | NEUROCRINE BIOSCIENCES INC | Sharp Shalini | Dir | M - OptEx | $0.00 | +1,435 | 2,429 | +144% | $0 |
| D | 2024-10-02 | 2024-09-30 | ONC | BeOne Medicines Ltd. | Sharp Shalini | Dir | A - Grant | $0.00 | +8,151 | 8,151 | New | $0 |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | Sharp Shalini | Dir | S - Sale+OE | $141.90 | -1,106 | 994 | -53% | -$156.9K |
| D | 2024-05-21 | 2024-05-17 | NBIX | NEUROCRINE BIOSCIENCES INC | Sharp Shalini | Dir | M - OptEx | $0.00 | +2,100 | 2,100 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations